Volume 10, Number 1—January 2004
Research
Ciprofloxacin-resistant Salmonella enterica Typhimurium and Choleraesuis from Pigs to Humans, Taiwan
Po-Ren Hsueh*†
, Lee-Jene Teng*†, Sung-Pin Tseng*, Chao-Fu Chang‡, Jen-Hsien Wan†, Jing-Jou Yan†, Chun-Ming Lee†, Yin-Ching Chuang†, Wen-Kuei Huang†, Dine Yang†, Jainn-Ming Shyr†, Kwok-Woon Yu†, Li-Shin Wang†, Jang-Jih Lu†, Wen-Chien Ko†, Jiunn-Jong Wu†, Feng-Yee Chang†, Yi-Chueh Yang†, Yeu-Jun Lau†, Yung-Ching Liu†, Cheng-Yi Liu†, Shen-Wu Ho†, and Kwen-Tay Luh*†
, Lee-Jene Teng*†, Sung-Pin Tseng*, Chao-Fu Chang‡, Jen-Hsien Wan†, Jing-Jou Yan†, Chun-Ming Lee†, Yin-Ching Chuang†, Wen-Kuei Huang†, Dine Yang†, Jainn-Ming Shyr†, Kwok-Woon Yu†, Li-Shin Wang†, Jang-Jih Lu†, Wen-Chien Ko†, Jiunn-Jong Wu†, Feng-Yee Chang†, Yi-Chueh Yang†, Yeu-Jun Lau†, Yung-Ching Liu†, Cheng-Yi Liu†, Shen-Wu Ho†, and Kwen-Tay Luh*†
Table 1
Number of ciprofloxacin-resistant nontyphoid Salmonella, S. enterica Typhimurium, and S. enterica Choleraesuis isolates from patients treated at 11 major teaching hospitals in different regions of Taiwan, March 2001–August 2001
| Hospital | % (no. ciprofloxacin-resistant isolates/no. total isolates) of ciprofloxacin-resistant isolates of total nontyphoid Salmonella | % (no.ciprofloxacin-resistant isolates/no. total isolates) of ciprofloxacin-resistant isolates, by serotype | ||
|---|---|---|---|---|
| Typhimurium | Choleraesuis | Others | ||
| Northern region | 4.3 (7/231) | 3.5 (3/85) | 7.7 (2/26) | 1.7 (2/120) |
| A | 0.0 (0/100) | 0.0 (0/40) | 0.0 (0/13) | 0.0 (0/47) |
| B | 8.2 (4/49) | 0.0 (0/19) | 28.5 (2/7) | 8.7 (2/23) |
| C | 1.7 (1/60) | 5.6 (1/18) | 0.0 (0/3) | 0.0 (0/39) |
| D | 9.1 (2/22) | 25.0 (2/8) | 0.0 (0/3) | 0.0 (0/11) |
| Central region | 3.9 (6/154) | 2.4 (2/85) | 6.1 (2/33) | 5.6 (2/36) |
| E | 5.3 (3/57) | 2.8 (1/36) | 7.1 (1/7) | 7.1 (1/14) |
| F | 7.7 (3/97) | 2.0 (1/49) | 3.8 (1/26) | 4.5 (1/22) |
| Southern region | 2.0 (5/255) | 0.0 (0/155) | 9.5 (4/42) | 1.7 (1/58) |
| G | 0.0 (0/99) | 0.0 (0/67) | 0.0 (0/11) | 0.0 (0/21) |
| H | 2.3 (2/86) | 0.0 (0/55) | 11.8 (2/17) | 0.0 (0/14) |
| I | 4.3 (3/70) | 0.0 (0/33) | 14.3 (2/14) | 4.3 (1/23) |
| Eastern region | ||||
| J | 0.0 (0/31) | 0.0 (0/22) | 0.0 (0/6) | 0.0 (0/3) |
| Total | 2.7 (18/671) | 1.4 (5/347) | 7.5 (8/107) | 2.3 (5/217) |
Page created: December 21, 2010
Page updated: December 21, 2010
Page reviewed: December 21, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.